Stock Earnings

Question 1

CytomX Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, CytomX Therapeutics Inc'in toplam varlıkları $120 olup, net profit $31'dir.

Question 2

CTMX'ün temel finansal oranları nelerdir?

Accepted Answer

CytomX Therapeutics Inc'in cari oranı 1, net kâr marjı 22.46, hisse başına satış $1.62'dir.

Question 3

CytomX Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

CytomX Therapeutics Inc largest revenue segment is Probody Therapeutics, at a revenue of 138,103,000 in the most earnings release.For geography, United States is the primary market for CytomX Therapeutics Inc, at a revenue of 138,103,000.

Question 4

CytomX Therapeutics Inc kârlı mı?

Accepted Answer

yes, son mali tablolara göre CytomX Therapeutics Inc'in net profit $31'dir.

Question 5

CytomX Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, CytomX Therapeutics Inc'in yükümlülüğü 120'dir.

Question 6

CytomX Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

CytomX Therapeutics Inc'in toplam tedavüldeki hisse sayısı 80.09'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	141	138	101	53	37	100
Revenue Growth (YoY)	18%	37%	91%	43%	-63%	75%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	29	29	30	40	39	36
Research & Development	68	83	77	106	114	112
Operating Expenses	97	113	107	146	153	149
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	48	32	3	-99	-115	-46
Income Tax Expense	0	0	3	0	0	-13
Net Income	47	31	0	-99	-115	-32
Net Income Growth	327%	--	-100%	-14%	259%	-69%
Shares Outstanding (Diluted)	129.07	84.74	73.8	65.7	64.1	46.1
Shares Change (YoY)	52%	15%	12%	3%	39%	2%
EPS (Diluted)	0.37	0.37	0	-1.51	-1.81	-0.71
EPS Growth	164%	-4,984%	-99%	-17%	155%	-69%
Free Cash Flow	-77	-86	-56	-112	-120	3
Free Cash Flow Per Share	-0.59	-1.01	-0.75	-1.7	-1.87	0.06
Gross Margin	--	--	--	--	--	--
Operating Margin	30.49%	17.39%	-5.94%	-175.47%	-313.51%	-48%
Profit Margin	33.33%	22.46%	0%	-186.79%	-310.81%	-32%
Free Cash Flow Margin	-54.6%	-62.31%	-55.44%	-211.32%	-324.32%	3%
EBITDA	44	25	-4	-91	-114	-46
EBITDA Margin	31.2%	18.11%	-3.96%	-171.69%	-308.1%	-46%
D&A For EBITDA	1	1	2	2	2	2
EBIT	43	24	-6	-93	-116	-48
EBIT Margin	30.49%	17.39%	-5.94%	-175.47%	-313.51%	-48%
Effective Tax Rate	0%	0%	100%	0%	0%	28.26%

CytomX Therapeutics Inc (CTMX) Price

CTMX Stock Price Chart

CTMX Income

Follow-Up Questions